837 results on '"Galetta, D."'
Search Results
202. Pneumonectomy with en bloc chest wall resection: is it worthwhile? Report on 34 patients from two institutions
203. miRNA profiling in serum and tissue samples to assess noninvasive biomarkers for NSCLC clinical outcome.
204. Efficacy of the Irreversible EGFR-HER2 Dual Inhibitor Afatinib in Pretreated Lung Adenocarcinoma
205. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals
206. Carinal resection
207. Completion pneumonectomy: a multicentre international study on 165 patients
208. Characterization of a serum protein pattern from NSCLC patients treated with Gefitinib
209. Updating data about a first-line modified schedule of gemcitabine with a lower dose than standard in very elderly or PS 2 patients with advanced non-small cell lung cancer.
210. Cisplatin, fotemustine and whole-brain radiotherapy in non-small cell lung cancer patients with asymptomatic brain metastases: A multicenter phase II study of the Gruppo Oncologico Italia Meridionale (GOIM 2603)
211. Impact of Genetic Variability in Nicotinic Acetylcholine Receptors on Nicotine Addiction and Smoking Cessation Treatment
212. Maintenance or non-maintenance therapy in the treatment of advanced non-small cell lung cancer: that is the question
213. 5 PANITUMUMAB PLUS CHEMOTHERAPY AS SALVAGE TREATMENT IN PRETREATED ADVANCED COLORECTAL CANCER PATIENTS: A SINGLE INSTITUTION'S EXPERIENCE
214. 40 ThinPrepR CYTOLOGICAL SPECIMENS ARE OFTEN MORE SUITABLE THAN HISTOLOGICAL SPECIMENS TO DETECT EGFR AND K-RAS MUTATIONS IN NSCLC AND COLORECTAL CARCINOMA
215. Apical Parietal Pleural Holes: What Are They?
216. 9085 A platinum based second line rechallenge chemotherapy improves survival in small cell lung cancer patients
217. First-line cisplatin (P) with docetaxel (TXT) or vinorelbine (VNR) in patients with advanced non-small cell lung cancer: A randomized phase II trial of the Gruppo Oncologico Italia Meridionale
218. Outcomes of small cell lung cancer (SCLC) patients treated with second-line chemotherapy (SL): A retrospective analysis of 166 patients
219. Activity and tolerability of cisplatin (CDDP) and fotemustine (FTM) in non-small cell lung cancer (NSCLC) patients (PTS) with brain metastases (BM): A multicentric phase II study of the Gruppo Oncologico dell’Italia Meridionale (GOIM)
220. Vascular Catheter Mimicking Persistent Left Superior Vena Cava
221. Focus on cosmesis in thymectomy for myasthenia gravis.
222. Activity and tolerability of Cisplatin (CDDP) and Fotemustine (FTM) combination in the treatment of patients with non-small cell lung cancer (NSCLC) with brain metastases (BM): A multicentric phase II study of the Gruppo Oncologico dell’Italia Meridionale (GOIM)
223. First-line cisplatin (P) with docetaxel (TXT) or vinorelbine (VNR) in patients with advanced non-small-cell lung cancer: A phase II randomized trial of Gruppo Oncologico Italia Meridionale
224. Electrochemotherapy (ECT) for the treatment of superficial tumor metastases
225. Finding the Limit between Station 2 and Station 4 during Right-Sided Thoracotomy
226. Challenging Diagnosis of an Unusual Solitary Pulmonary Nodule
227. Anterior approach for Pancoast tumor resection
228. A factorial phase III randomized trial of rofecoxib and prolonged constant infusion of gemcitabine at 10mg/m2/min (PCI-G) in first-line treatment of adult patients (pts) with advanced non-small cell lung cancer (NSCLC): The GECO study
229. Neoadjuvant chemotherapy followed by extrapleural pneumonectomy (EPP) for malignant pleural mesothelioma (MPM): An Italian experience with cisplatin-based regimens
230. Superior vena cava resection for lung and mediastinal malignancies
231. O-090 Weekly vinorelbine plus cisplatin versus day 1+8 vinorelbine withcisplatin in advanced non small cell lung cancer: End results of a phase III trial
232. Outcome of patients with advanced non-small-cell lung cancer and ECOG performance status 2: A retrospective analysis of the GOIM trials
233. MIX (mitomycin C, irinotecan, capecitabine) regimen in the treatment of advanced gastric cancer (AGC). A phase I study of the Gruppo Oncologico dell’Italia Meridionale (GOIM)
234. Symptom-free T4 lung cancer with bilateral pulmonary artery infiltration
235. A phase II trial of topotecan and ifosfamide in patients with previously treated, advanced non small cell lung carcinoma (NSCLC)
236. Results of thoracoscopic pleural abrasion for primary spontaneous pneumothorax
237. Granulome pulmonaire hyalinisant avec fibrose médiastinale : une cause rare de dysphagie
238. Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized Trial
239. 1278P - Be-Positive: Beyond Progression After Tyrosine Kinase Inhibitor in Egfr-Positive Non-Small Cell Lung Cancer (Nsclc) Patients. Preliminary Results from a Multicenter Italian Observational Study
240. Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial
241. Left Bronchial Disruption and Aortic Rupture after Blunt Chest Trauma
242. Mediastinoscopy as a standardised procedure for mediastinal lymph-node staging in non-small cell carcinoma. Do we have to accept the compromise?
243. Topoisomerase-1 (topo-I) and thymidylate synthase (TS) primary tumor expression as prognostic and predictive factors for response to cpt-11 in advanced colorectal cancer (crc) patients
244. Randomized phase III trial of the Southern Italy Oncology Group comparing sequential ifosfamide + gemcitabine followed by cisplatin + navelbine (IG -> PN) versus the opposite sequence (PN -> IG) versus cisplatin + navelbine (PN) versus gemcitabine + cisplatin (GP) in stage III–IV non small cell lung cancer (NSCLC)
245. A randomized phase III trial of the Southern Italy Oncology Group (G.O.I.M.). of mitomycin C plus vindesine and cisplatin (MVP regimen) versus vinorelbine plus cisplatin (PV regimen) in stage III–IV non small cell lung cancer
246. Cisplatin, Interleukin-2, Interferon-α and Tamoxifen in Metastatic Melanoma. A Phase II Study
247. P40.01 Tobacco use in Adolescence and Associated Factors: Products, School, Family, Peers and Movies in Pandemic Period.
248. FP06.04 Psychological Distress in Outpatients with Lymphoma, Lung and Breast Cancer during COVID-19 pandemic.
249. Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM)
250. ELFE (etoposide, folinic acid, 5-fluorouracil, and epirubicin) regimen in the treatment of advanced pancreatic cancer (APC)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.